logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cardiovascular Disease In The Uremic Patient Cardionephrology Symposium Hannelore Hampl Anatole Besarab

  • SKU: BELL-4116536
Cardiovascular Disease In The Uremic Patient Cardionephrology Symposium Hannelore Hampl Anatole Besarab
$ 31.00 $ 45.00 (-31%)

5.0

78 reviews

Cardiovascular Disease In The Uremic Patient Cardionephrology Symposium Hannelore Hampl Anatole Besarab instant download after payment.

Publisher: Karger
File Extension: PDF
File size: 2.3 MB
Pages: 106
Author: Hannelore Hampl; Anatole Besarab
ISBN: 9783805580588, 3805580584
Language: English
Year: 2005

Product desciption

Cardiovascular Disease In The Uremic Patient Cardionephrology Symposium Hannelore Hampl Anatole Besarab by Hannelore Hampl; Anatole Besarab 9783805580588, 3805580584 instant download after payment.

Uremia, which is associated with the deterioration of renal function, is a complex process that influences all cardiac structures. The most important manifestations of this disorder are hypertensive and anemic heart disease, coronary artery disease and heart valve diseases. Cardiovascular diseases are thus the primary cause of death in patients on hemodialysis. This book presents strategies to significantly reduce cardiac morbidity/mortality in uremic patients. The topics include the role of oxidative stress (caused by anemia) in cardiovascular injury and the correction of anemia by means of erythropoietin. This correction also significantly reduces increased oxidized lipoprotein species, key factors of arteriosclerosis. Another risk factor which is discussed is severe left-ventricular hypertrophy (LVH), which predisposes ventricular arrhythmia triggered by critically reduced coronary reserve, often leading to sudden death

Related Products